Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)

NCT02566811 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
49
Enrollment
OTHER
Sponsor class

Stopped Withdrawal of funding by CR UK due to poor recruitment

Conditions

Interventions

Sponsor

University College, London